This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Manufacturing & Commercialization US
September 23-26, 2024
Hynes Convention CenterBoston, MA


Stream1: Cell and Gene Therapy Bioprocessing

  • Investigate monitoring quality across your process with PAT, QbD and novel analytical methods
  • Get top tips on the application of process automation and closed systems in manufacturing
  • Dive into costs of goods calculations and considerations

Stream 2: Cell and Gene Therapy Commercialization

  • Making the decision to either insource or outsource manufacturing? What’s the best choice?
  • Hear the latest on designing a manufacturing facility to meet scaling up and out requirements
  • Put yourself in the shoes of Novartis or Kite – a retrospective look at 2017

Stream 3: Pre-clinical and Clinical Development for Cell and Gene Therapies

  • Get the latest on current development pipelines –optimise preclinical models and examine novel targets
  • Pick up knowledge on pre-clinical regulatory and process considerations for entering the clinic
  • Push the boundaries of collaboration for end-to-end solutions in preclinical and clinical research

Stream 4: Logistics, Supply Chain, and Cryopreservation Techniques

  • Immerse yourself in cryopreservation – considerations when moving from clinical phase to commercial
  • Understand vein-to-vein supply chain and transportation strategies
  • Master chain of identity, analytical considerations and patient specific batches